These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 2771118)
1. [Cancer of the breast. II. Prognostic factors (our experience)]. Macellari G; Giarelli C Minerva Chir; 1989 Jun; 44(12):1659-63. PubMed ID: 2771118 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Lee AH; Pinder SE; Macmillan RD; Mitchell M; Ellis IO; Elston CW; Blamey RW Eur J Cancer; 2006 Feb; 42(3):357-62. PubMed ID: 16377180 [TBL] [Abstract][Full Text] [Related]
3. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151 [TBL] [Abstract][Full Text] [Related]
4. Lack of prognostic significance of histological grade in node-negative invasive breast carcinoma. Younes M; Laucirica R Clin Cancer Res; 1997 Apr; 3(4):601-4. PubMed ID: 9815726 [TBL] [Abstract][Full Text] [Related]
5. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast. Pervez S; Khan MN; Nasir MI J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469 [TBL] [Abstract][Full Text] [Related]
6. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor. Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658 [TBL] [Abstract][Full Text] [Related]
7. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375 [TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors. Pirinen R; Lipponen P; Syrjänen K Anticancer Res; 1995; 15(6B):2835-40. PubMed ID: 8669874 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma. Bièche I; Lazar V; Noguès C; Poynard T; Giovangrandi Y; Bellet D; Lidereau R; Vidaud M Clin Cancer Res; 1998 Mar; 4(3):671-6. PubMed ID: 9533536 [TBL] [Abstract][Full Text] [Related]
10. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients]. Jakić-Razumović J; Corić M; Vrbanec D; Babić D; Hlupić L; Belev B Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866 [TBL] [Abstract][Full Text] [Related]
11. [Cancer of the breast. I. Epidemiology and risk factors (our experience)]. Macellari G; Giarelli C Minerva Chir; 1989 Jun; 44(12):1655-8. PubMed ID: 2771117 [TBL] [Abstract][Full Text] [Related]
12. Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy. Michels JJ; Duigou F; Marnay J; Denoux Y; Delozier T; Chasle J Cytometry B Clin Cytom; 2003 Sep; 55(1):37-45. PubMed ID: 12949958 [TBL] [Abstract][Full Text] [Related]
13. A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy. Kattan MW; Giri D; Panageas KS; Hummer A; Cranor M; Van Zee KJ; Hudis CA; Norton L; Borgen PI; Tan LK Cancer; 2004 Dec; 101(11):2509-15. PubMed ID: 15495180 [TBL] [Abstract][Full Text] [Related]
14. Proliferative activity in primary breast carcinomas is a salient prognostic factor. Michels JJ; Marnay J; Delozier T; Denoux Y; Chasle J Cancer; 2004 Feb; 100(3):455-64. PubMed ID: 14745860 [TBL] [Abstract][Full Text] [Related]
15. Survival of women with node negative breast cancer in the Auckland region. Lethaby AE; Mason BH; Harvey VJ; Holdaway IM N Z Med J; 1996 Sep; 109(1029):330-3. PubMed ID: 8862351 [TBL] [Abstract][Full Text] [Related]
16. Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma. Methodological aspects and prognostic value in a series of 257 cases. Caly M; Genin P; Ghuzlan A A; Elie C; Fréneaux P; Klijanienko J; Rosty C; Sigal-Zafrani B; Vincent-Salomon A; Douggaz A; Zidane M; Sastre-Garau X Anticancer Res; 2004; 24(5B):3283-8. PubMed ID: 15510624 [TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of resectable breast cancer: a report of 6 263 cases]. Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535 [TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer. Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996 [TBL] [Abstract][Full Text] [Related]
19. Proliferation in African breast cancer: biology and prognostication in nigerian breast cancer material. Ikpatt OF; Kuopio T; Collan Y Mod Pathol; 2002 Aug; 15(8):783-9. PubMed ID: 12181262 [TBL] [Abstract][Full Text] [Related]
20. The effect of tumor size and lymph node status on breast carcinoma lethality. Michaelson JS; Silverstein M; Sgroi D; Cheongsiatmoy JA; Taghian A; Powell S; Hughes K; Comegno A; Tanabe KK; Smith B Cancer; 2003 Nov; 98(10):2133-43. PubMed ID: 14601082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]